Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Profit After Tax (2016 - 2026)

Wave Life Sciences filings provide 12 years of Profit After Tax readings, the most recent being -$26.1 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 44.35% to -$26.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$183.6 million, a 63.44% decrease, with the full-year FY2025 number at -$204.4 million, down 110.68% from a year prior.
  • Profit After Tax hit -$26.1 million in Q1 2026 for Wave Life Sciences, up from -$53.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $29.3 million in Q4 2024 to a low of -$61.8 million in Q3 2024.
  • Median Profit After Tax over the past 5 years was -$37.8 million (2022), compared with a mean of -$32.2 million.
  • The widest YoY moves for Profit After Tax: up 279.95% in 2024, down 951.9% in 2024.
  • Wave Life Sciences' Profit After Tax stood at -$43.7 million in 2022, then surged by 62.81% to -$16.3 million in 2023, then soared by 279.95% to $29.3 million in 2024, then plummeted by 281.79% to -$53.2 million in 2025, then surged by 50.94% to -$26.1 million in 2026.
  • The last three reported values for Profit After Tax were -$26.1 million (Q1 2026), -$53.2 million (Q4 2025), and -$53.9 million (Q3 2025) per Business Quant data.